Judges Scientific (LSE:JDG) has told investors that it is counting on a strong final quarter to meet full-year expectations after a first half its chairman described as very poor. In interim results published on 23 September 2026, the scientific instrument group reported a 21% fall in revenue to £55.7 million and a statutory loss before tax of £1.7 million, but kept its full-year guidance unchanged and raised its interim dividend by 10%.
What Judges Scientific Does
Judges Scientific is a buy-and-build group that acquires and owns small, specialist businesses designing and manufacturing scientific instruments. Its subsidiaries serve universities, research institutions and industrial customers around the world, with products used in areas such as materials testing, geoscience and laboratory research. The model relies on buying niche, cash-generative companies at modest valuations and recycling their cash flows into further acquisitions, while each business continues to operate with a high degree of autonomy.
Latest Developments
The six months to 30 June 2026 were affected by several headwinds. The company said around 8% of the revenue decline reflected the absence of a coring expedition at its Geotek subsidiary, which had boosted the prior-year period, while a further net 13% came from weaker conditions linked to US research funding, offshore wind and China, partly offset by growth at eight of its businesses. Adjusted operating profit dropped 66% to £4.8 million, and adjusted basic earnings per share fell 72% to 39.0p.
Order intake was 12% lower than a year earlier across the half, with the first quarter down 18% and the second quarter closer to the prior year. Encouragingly, the company said second-half intake to the date of the report was only 1% behind the previous year, and chief executive Tim Prestidge called order intake since the period end encouraging. The order book stood at 17.3 weeks, almost unchanged on a year earlier. The company also announced that chief financial officer Brad Ormsby will step down, remaining for up to 12 months, and said the next Geotek coring expedition is now expected no earlier than 2028.
Financial and Dividend Picture
The interim dividend was raised to 36.0p from 32.7p and is payable on 6 November 2026 to shareholders on the register on 9 October. The company acknowledged that cover of 1.1 times adjusted earnings was not sustainable. Adjusted net debt rose to £45.3 million from £42.6 million at the end of 2025, with gearing increasing to 2.1 times, and banking facilities were extended to July 2030. No acquisitions were completed in the half, although management described the pipeline as healthy. The board expects full-year adjusted earnings per share in line with market expectations, which the company put at 200.5p. The shares were down 1.32% at 3,740p on results day.
Sector and Index Context
Judges Scientific is a constituent of the FTSE AIM All Share Index. The scientific instrument sector has been affected by pressure on US government research budgets, softer demand from China and a slowdown in offshore wind investment.
Key Risks
The heavy weighting of revenue towards the fourth quarter introduces execution risk, which management described as largely manageable. Continued weakness in research funding, higher gearing and the absence of a Geotek expedition in 2027 are further concerns, as is the need to resume acquisitions to sustain the growth model. A change of finance director adds a period of transition.
What to Watch Next
Investors will look for a year-end trading update confirming that fourth-quarter deliveries have landed, further data on order intake and any new acquisitions. Progress in recruiting a successor finance director will also be followed.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...